Clinical Trial

GDM: Insulin with or Without Metformin?

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated January 17, 2025 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This will be a randomized trial of patients with gestational diabetes who start hypoglycemic therapy with metformin but eventually require insulin. It will examine whether continuing metformin when adding insulin versus discontinuing metformin when insulin is added is beneficial. The investigators hypothesize that continuing metformin will reduce the needed insulin dosage and improve maternal and neonatal outcomes in these patients.
Trial Details
NCT Number NCT06781775
Lead Sponsor University of Virginia
Conditions Gestational Diabetes
Enrollment 130 participants
Start Date 2024-12-12
Primary Completion 2026-05-01 (estimated)
Study Completion 2027-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-01-17